158 related articles for article (PubMed ID: 38651850)
21. Screening for second malignancies in mycosis fungoides: non-Hodgkin lymphoma, Hodgkin lymphoma, lung cancer, bladder cancer and melanoma.
Goyal A; O'Leary D; Goyal K; Rubin N; Janakiram M
J Eur Acad Dermatol Venereol; 2021 Sep; 35(9):1821-1829. PubMed ID: 34013554
[TBL] [Abstract][Full Text] [Related]
22. Follicular mucinosis in patients with hematologic malignancies other than mycosis fungoides: A clinicopathologic study.
Geller S; Gomez CJ; Myskowski PL; Pulitzer M
J Am Acad Dermatol; 2019 Jun; 80(6):1704-1711. PubMed ID: 30716405
[TBL] [Abstract][Full Text] [Related]
23. Optimal panel of immunohistochemistry for the diagnosis of B-cell non-Hodgkin lymphoma using bone marrow biopsy: a tertiary care center study.
Marwah N; Satiza M; Dalal N; Atri S; Gupta M; Singh S; Sen R
Blood Res; 2021 Mar; 56(1):26-30. PubMed ID: 33504685
[TBL] [Abstract][Full Text] [Related]
24. Mycosis fungoides and chronic lymphocytic leukaemia--composite T-cell and B-cell lymphomas presenting in the skin.
Hull PR; Saxena A
Br J Dermatol; 2000 Aug; 143(2):439-44. PubMed ID: 10951162
[TBL] [Abstract][Full Text] [Related]
25. Hodgkin Variant of Richter's Transformation in Chronic Lymphocytic Leukemia (CLL): An Illustrative Case Report and Literature Review.
Gupta N; Mittal A; Duggal R; Dadu T; Agarwal A; Handoo A
Int J Hematol Oncol Stem Cell Res; 2021 Oct; 15(4):249-254. PubMed ID: 35291669
[TBL] [Abstract][Full Text] [Related]
26. Leukemic phase of B-cell lymphomas mimicking chronic lymphocytic leukemia and variants at presentation.
Nelson BP; Variakojis D; Peterson LC
Mod Pathol; 2002 Nov; 15(11):1111-20. PubMed ID: 12429788
[TBL] [Abstract][Full Text] [Related]
27. Recognizing large-cell transformation of mycosis fungoides.
Herrmann JL; Hughey LC
J Am Acad Dermatol; 2012 Oct; 67(4):665-72. PubMed ID: 22261416
[TBL] [Abstract][Full Text] [Related]
28. Mycosis fungoides with CD20 expression: report of two cases and review of the literature.
Harms KL; Harms PW; Anderson T; Betz BL; Ross CW; Fullen DR; Hristov AC
J Cutan Pathol; 2014 Jun; 41(6):494-503. PubMed ID: 24467775
[TBL] [Abstract][Full Text] [Related]
29. Second Primary Malignancies in CTCL Patients from 1992 to 2011: A SEER-Based, Population-Based Study Evaluating Time from CTCL Diagnosis, Age, Sex, Stage, and CD30+ Subtype.
Amber KT; Bloom R; Nouri K
Am J Clin Dermatol; 2016 Feb; 17(1):71-7. PubMed ID: 26386881
[TBL] [Abstract][Full Text] [Related]
30. The relevance of peripheral blood T-helper 1 and 2 cytokine pattern in the evaluation of patients with mycosis fungoides and Sézary syndrome.
Papadavid E; Economidou J; Psarra A; Kapsimali V; Mantzana V; Antoniou C; Limas K; Stratigos A; Stavrianeas N; Avgerinou G; Katsambas A
Br J Dermatol; 2003 Apr; 148(4):709-18. PubMed ID: 12752128
[TBL] [Abstract][Full Text] [Related]
31. Cutaneous composite lymphoma of mycosis fungoides and Hodgkin lymphoma: Response to sequential therapy.
Chen Y; Nong L; Li X; Wang Y
J Cutan Pathol; 2020 Sep; 47(9):829-833. PubMed ID: 32285466
[TBL] [Abstract][Full Text] [Related]
32. Cutaneous T-cell lymphoma is associated with increased risk of lymphoma, melanoma, lung cancer, and bladder cancer.
Goyal A; O'Leary D; Goyal K; Patel K; Pearson D; Janakiram M
J Am Acad Dermatol; 2021 Dec; 85(6):1418-1428. PubMed ID: 32822803
[TBL] [Abstract][Full Text] [Related]
33. Mycosis fungoides in plaque stage with pronounced eosinophilic infiltration, folliculotropism, and concomitant invasive squamous cell carcinoma.
Terada T
Int J Clin Exp Pathol; 2013; 6(4):749-56. PubMed ID: 23573323
[TBL] [Abstract][Full Text] [Related]
34. Response to brentuximab vedotin versus physician's choice by CD30 expression and large cell transformation status in patients with mycosis fungoides: An ALCANZA sub-analysis.
Kim YH; Prince HM; Whittaker S; Horwitz SM; Duvic M; Bechter O; Sanches JA; Stadler R; Scarisbrick J; Quaglino P; Zinzani PL; Wolter P; Eradat H; Pinter-Brown LC; Ortiz-Romero PL; Akilov OE; Trotman J; Taylor K; Weichenthal M; Walewski J; Fisher D; McNeeley M; Gru AA; Brown L; Palanca-Wessels MC; Lisano J; Onsum M; Bunn V; Little M; Trepicchio WL; Dummer R
Eur J Cancer; 2021 May; 148():411-421. PubMed ID: 33794441
[TBL] [Abstract][Full Text] [Related]
35. Concurrent mycosis fungoides and intravascular large B-cell lymphoma in a single patient.
Goyal A; Totoraitis K; Toama W; He F; Bohjanen K; Williams S; Miller DD
J Cutan Pathol; 2020 Jul; 47(7):643-648. PubMed ID: 32087036
[TBL] [Abstract][Full Text] [Related]
36. IgVH mutational status and clonality analysis of Richter's transformation: diffuse large B-cell lymphoma and Hodgkin lymphoma in association with B-cell chronic lymphocytic leukemia (B-CLL) represent 2 different pathways of disease evolution.
Mao Z; Quintanilla-Martinez L; Raffeld M; Richter M; Krugmann J; Burek C; Hartmann E; Rudiger T; Jaffe ES; Müller-Hermelink HK; Ott G; Fend F; Rosenwald A
Am J Surg Pathol; 2007 Oct; 31(10):1605-14. PubMed ID: 17895764
[TBL] [Abstract][Full Text] [Related]
37. Spatially Resolved Transcriptomes of CD30+-Transformed Mycosis Fungoides and Cutaneous Anaplastic Large-Cell Lymphoma.
Choi ME; Lee MY; Won CH; Chang SE; Lee MW; Lee WJ
J Invest Dermatol; 2024 Feb; 144(2):331-340.e2. PubMed ID: 37544586
[TBL] [Abstract][Full Text] [Related]
38. An unusual case of systemic mastocytosis associated with chronic lymphocytic leukaemia (SM-CLL).
Horny HP; Sotlar K; Stellmacher F; Valent P; Grabbe J
J Clin Pathol; 2006 Mar; 59(3):264-8. PubMed ID: 16505276
[TBL] [Abstract][Full Text] [Related]
39. Transformed mycosis fungoides: clinicopathological features and outcome.
Barberio E; Thomas L; Skowron F; Balme B; Dalle S
Br J Dermatol; 2007 Aug; 157(2):284-9. PubMed ID: 17573879
[TBL] [Abstract][Full Text] [Related]
40. [Chronic lymphocytic leukaemia presenting with specific cutaneous infiltrates in the absence of lymphocytosis: Two cases].
Vonarx M; Carpentier O; Cazin B; Bouchindhomme B; Delaporte E
Ann Dermatol Venereol; 2012 Oct; 139(10):641-6. PubMed ID: 23122378
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
